You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Orexo AB v. Actavis Elizabeth LLC (D. Del. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Orexo AB v. Actavis Elizabeth LLC (D. Del. 2014)

Docket ⤷  Sign Up Date Filed 2014-06-26
Court District Court, D. Delaware Date Terminated 2019-01-10
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand Defendant Referred To Sherry R. Fallon
Parties ACTAVIS ELIZABETH LLC; ACTAVIS INC.
Patents 6,761,910; 8,454,996; 8,470,361; 8,475,832; 8,512,747; 8,658,198; 8,940,330
Attorneys Anna Brook; Derek James Fahnestock
Firms Barnes and Thornburg LLP; Phillips, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Orexo AB v. Actavis Elizabeth LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for Orexo AB v. Actavis Elizabeth LLC (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2014-06-26 1 29. United States Patent No. 8,470,361 (“the ’361 patent,” copy attached as Exhibit B) …COUNT II Infringement of U.S. Patent No. 8,470,361 Under 35 U.S.C. § 271 44.… the expiration of the ’996 patent, the ’361 patent, and the ’198 patent. …”) with respect to the ’996 patent, the ’361 patent, and the ’198 patent. On information and belief, … of its knowledge, the ’996 patent, the ’361 patent, and the ’198 patent are invalid and/or will not External link to document
2015-09-21 120 1 U.S. Patent Nos. 8,454,996 (“the ’996 patent”) and 8,940,330 (“the ’330 patent”). Case 1:14-cv… The samples in question are relevant. The patents in this case1 require specific relationships …materials in the claimed formulations: The ’996 patent claims a tablet with particles of buprenorphine…particles. (D.I. 54-1, ’996 pat. claims). The ’330 patent claims a tablet with particles of buprenorphine…particles “adhere” as required by some asserted patent claims and other relationships between particles External link to document
2015-10-06 127 disputed claim language of U.S. Patent Nos. 8,454,996 ("the '996 patent") and 8,940,330 ("…acceptable substances. 3 ('330 patent, 7:28-30; '996 patent, 4:41-43) 1 Found in claims 1 …and 2 of the '996 patent and in claims 1, 3-6, 10 of the '330 patent. 2 This construction is…agents .... " ('996 patent, abstract; 2:64-67) The '996 patent explains that "a bio/mucoadhesion…claim 1 of the '996 patent. 5 Found in claim 1 of the '330 patent. External link to document
2016-11-14 228 alleging infringement of U.S. Patent Nos. 8,454,996 ("the '996 patent") and 8,940,330 ("…x27;996 patent. 38 Claim 2 of the '996 patent. 39Claim 1 of the '330 patent. Actavis… 2. The '996 patent The '996 patent, titled "Pharmaceutical Composition…with carrier particles. ('996 patent, 12: 18-43) The patent states that using "ordered mixtures… useful results." ('996 patent, 3:56-61) The patent explains that "[a] variety of polymers External link to document
2019-01-09 255 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,454,996; 8,940,330. (Attachments…2014 10 January 2019 1:14-cv-00829 830 Patent Defendant District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.